ST. LOUIS--(BUSINESS WIRE)--Canopy Biosciences, a Bruker Company, today announced the commercial launch of the CellScape TM system, the next generation in ChipCytometry TM instrumentation, advancing ...
Functional classification of tumor biomarkers by molecular type and clinical applications. Tumor biomarkers are categorized into genetic, protein, epigenetic, and metabolic types, each associated with ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vizgen, Inc., the life sciences company revolutionizing spatial genomics research and driving innovation in spatial multi-omics, today announced the official launch ...
A new artificial intelligence-powered tool called MISO (Multi-modal Spatial Omics) can detect cell-level characteristics of cancer by looking at data from extremely small pieces of tissue-some as ...
This illustration summarizes how integrated spatial transcriptomics, single-cell transcriptomics, single-cell epigenomics, and spatial epigenomics enable multi-dimensional profiling of the tumor ...
Next-generation sequencing (NGS) was developed at the turn of the millennium, and the first complete sequence of the human genome was achieved in 2022. Recent technological developments now allow us ...
A new tool developed by Helmholtz Munich and the German Center for Diabetes Research and the University of Bonn makes spatial proteomics and lipidomics easier to use—no coding required. C-COMPASS ...
Vizgen, Inc., a spatial multi-omics innovator accelerating biological discovery and new drug development, today announced that it will present new spatial multi-omics data at the Society for ...
From startups to giants in pharma and tools, the use of spatial biology is growing in importance in drug discovery. LatchBio, a four-year-old San Francisco builder of software and data infrastructure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results